SCHEMBL4192467

SCHEMBL4192467

C[C@@H](CC1CCCCC1)NCc1ccccc1NS(=O)(=O)c1cc2cc(F)ccc2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
DRD2 P14416 4/20 0.33
HTR2A P28223 4/20 0.33
HTR7 P34969 3/20 0.33
HTR6 P50406 3/20 0.33
PI4KB Q9UBF8 1/20 0.33
HTR1A P08908 2/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
KCNH2 Q12809 1/20 0.33
CCR2 P41597 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197433 1.00 KDM4E (0.38) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4198286 0.99 KDM4E (0.36) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4195304 0.90 CCR2 (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4200095 0.90 CCR2 (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4197675 0.90 CCR2 (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4186605 0.90 LMNA (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4192385 0.89 CCR2 (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4190584 0.89 GHSR (0.41) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4190303 0.89 CA2 (0.37) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4202537 0.87 HTR1A (0.41) KDM4EPKMALDH1A1POLBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885ALDH1A1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.